EU Seeks Up to 300 Million More Pfizer-BioNTech Doses

0 2

Get real time updates directly on you device, subscribe now.




Source: Bloomberg




By Naomi Kresge and John Follain



The European Union is negotiating with Pfizer Inc. and BioNTech SE on a deal that could double their supply of Covid-19 vaccine to the region as countries race to immunize enough people to tame a fresh virus resurgence.

The new contract would include 100 million doses, as well as an option for as many as 200 million more, according to people familiar with the talks who asked not to be identified because the negotiations are private.

Biontech

Governments across the EU face growing questions over the slow pace of their vaccine rollouts, and shots from other drugmakers such as AstraZeneca Plc won’t be available for weeks at the earliest.

The attempt to secure more of the Pfizer-BioNTech vaccine comes less than a week after the 27-member bloc boosted its original 200 million-dose order to 300 million. If the option in the new agreement were exercised, it would lift the total doses to 600 million, enough to vaccinate two-thirds of the bloc’s population based on a two-dose regimen.

Read further

Subscribe to our newsletter
Sign up here to get the latest news, updates delivered directly to your inbox.
You can unsubscribe at any time

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy